Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 261

1.

Transformation to small cell lung cancer and activation of KRAS during long-term erlotinib maintenance in a patient with non-small cell lung cancer: A case report.

Gu Y, Zhu X, Cao B, Wu X, Tong X, Shao YW, Liang L.

Oncol Lett. 2019 Jun;17(6):5219-5223. doi: 10.3892/ol.2019.10196. Epub 2019 Mar 28.

2.

Association of maternal folate intake during pregnancy with infant asthma risk.

Li W, Xu B, Cao Y, Shao Y, Wu W, Zhou J, Tan X, Wu X, Kong J, Hu C, Xie K, Wu J.

Sci Rep. 2019 Jun 6;9(1):8347. doi: 10.1038/s41598-019-44794-z.

3.

Improving the Thermal Stability of Hydrophobic Associative Polymer Aqueous Solution Using a "Triple-Protection" Strategy.

Yang B, Mao J, Zhao J, Shao Y, Zhang Y, Zhang Z, Lu Q.

Polymers (Basel). 2019 Jun 1;11(6). pii: E949. doi: 10.3390/polym11060949.

4.

Nkx2-4 Mutation Confers Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Sarcomatoid Carcinoma.

Xia L, Shao YW, Xia Y.

J Thorac Oncol. 2019 Jun;14(6):e125-e126. doi: 10.1016/j.jtho.2019.01.027. No abstract available.

PMID:
31122564
5.

Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma.

Ye M, Lv J, Xu G, Wang W, Jing Y, Sun A, Lu Z, Wu X, Liu Y, Shao YW, Liu F, Tao F.

J Int Med Res. 2019 Jun;47(6):2768-2777. doi: 10.1177/0300060519847796. Epub 2019 May 20.

PMID:
31106632
6.

Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti-PD-(L)1 Therapies in Non-Small-Cell Lung Cancer.

Fang W, Ma Y, Yin JC, Hong S, Zhou H, Wang A, Wang F, Bao H, Wu X, Yang Y, Huang Y, Zhao H, Shao YW, Zhang L.

Clin Cancer Res. 2019 May 13. pii: clincanres.0585.2019. doi: 10.1158/1078-0432.CCR-19-0585. [Epub ahead of print]

PMID:
31085721
7.

Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.

Lin C, Shi X, Yang S, Zhao J, He Q, Jin Y, Yu X.

Lung Cancer. 2019 May;131:62-68. doi: 10.1016/j.lungcan.2019.03.018. Epub 2019 Mar 20.

PMID:
31027700
8.

Vertical distribution of 129I and radiocesium in forest soil collected near the Fukushima Daiichi Nuclear Power Plant boundary.

Yang G, Hu J, Tsukada H, Tazoe H, Shao Y, Yamada M.

Environ Pollut. 2019 Jul;250:578-585. doi: 10.1016/j.envpol.2019.04.053. Epub 2019 Apr 13.

PMID:
31026706
9.

Evaluating the sustainable traffic flow operational features of an exclusive spur dike U-turn lane design.

Shao Y, Han X, Wu H, Shan H, Yang S, Claudel CG.

PLoS One. 2019 Apr 10;14(4):e0214759. doi: 10.1371/journal.pone.0214759. eCollection 2019.

10.

Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI-Treated Non-Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy.

Ding M, Deng L, Yu R, Lu D, Bai Y, Wu X, Shao YW, Yang Y.

Clin Lung Cancer. 2019 May;20(3):e229-e232. doi: 10.1016/j.cllc.2019.02.014. Epub 2019 Feb 27. No abstract available.

PMID:
30948231
11.
12.

Author Correction: Draft genomic and transcriptome resources for marine chelicerate Tachypleus tridentatus.

Liao YY, Xu PW, Kwan KY, Ma ZY, Fang HY, Xu JY, Wang PL, Yang SY, Xie SB, Xu SQ, Dan Qian, Li WF, Bai LR, Zhou DJ, Zhang YQ, Lei J, Liu K, Li F, Li J, Zhu P, Wang YJ, Wu HP, Xu YH, Huang H, Zhang C, Liu JX, Han JF.

Sci Data. 2019 Mar 26;6(1):11. doi: 10.1038/s41597-019-0025-6.

13.

236U and radiocesium in river bank soil and river sediment in Fukushima Prefecture, after the Fukushima Daiichi Nuclear Power Plant accident.

Yang G, Rahman MS, Tazoe H, Hu J, Shao Y, Yamada M.

Chemosphere. 2019 Jun;225:388-394. doi: 10.1016/j.chemosphere.2019.03.061. Epub 2019 Mar 12.

PMID:
30884300
14.

Mutation Profile of Resected EGFR-Mutated Lung Adenocarcinoma by Next-Generation Sequencing.

Zhao ZR, Lin YB, Ng CSH, Zhang R, Wu X, Ou Q, Chen W, Zhou WJ, Lin YB, Su XD, Shao YW, Long H.

Oncologist. 2019 Mar 14. pii: theoncologist.2018-0567. doi: 10.1634/theoncologist.2018-0567. [Epub ahead of print]

PMID:
30872465
15.

Draft genomic and transcriptome resources for marine chelicerate Tachypleus tridentatus.

Liao YY, Xu PW, Kwan KY, Ma ZY, Fang HY, Xu JY, Wang PL, Yang SY, Xie SB, Xu SQ, Qian D, Li WF, Bai LR, Zhou DJ, Zhang YQ, Lei J, Liu K, Li F, Li J, Zhu P, Wang YJ, Wu HP, Xu YH, Huang H, Zhang C, Liu JX, Han JF.

Sci Data. 2019 Feb 26;6:190029. doi: 10.1038/sdata.2019.29. Erratum in: Sci Data. 2019 Mar 26;6(1):11.

16.

BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress.

Fernando TM, Marullo R, Pera Gresely B, Phillip JM, Yang SN, Lundell-Smith G, Torregroza I, Ahn H, Evans T, Győrffy B, Privé GG, Hirano M, Melnick AM, Cerchietti L.

Cancer Discov. 2019 May;9(5):662-679. doi: 10.1158/2159-8290.CD-17-1444. Epub 2019 Feb 18.

PMID:
30777872
17.

Widespread and Functional RNA Circularization in Localized Prostate Cancer.

Chen S, Huang V, Xu X, Livingstone J, Soares F, Jeon J, Zeng Y, Hua JT, Petricca J, Guo H, Wang M, Yousif F, Zhang Y, Donmez N, Ahmed M, Volik S, Lapuk A, Chua MLK, Heisler LE, Foucal A, Fox NS, Fraser M, Bhandari V, Shiah YJ, Guan J, Li J, Orain M, Picard V, Hovington H, Bergeron A, Lacombe L, Fradet Y, Têtu B, Liu S, Feng F, Wu X, Shao YW, Komor MA, Sahinalp C, Collins C, Hoogstrate Y, de Jong M, Fijneman RJA, Fei T, Jenster G, van der Kwast T, Bristow RG, Boutros PC, He HH.

Cell. 2019 Feb 7;176(4):831-843.e22. doi: 10.1016/j.cell.2019.01.025.

PMID:
30735634
18.

Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA.

Sun P, Chen C, Xia Y, Wang Y, Liu PP, Bi XW, Shao YW, Ou QX, Wu X, Yang H, Nie M, Zhang XW, Li ZM, Jiang WQ.

J Cancer. 2019 Jan 1;10(2):323-331. doi: 10.7150/jca.27615. eCollection 2019.

19.

Lung Adenocarcinoma Harboring EGFR 19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy.

Wang X, Zhou L, Yin JC, Wu X, Shao YW, Gao B.

J Thorac Oncol. 2019 May;14(5):e85-e88. doi: 10.1016/j.jtho.2019.01.015. Epub 2019 Jan 31. No abstract available.

PMID:
30711650
20.

Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non-small-cell Lung Cancer.

Wang B, Gao Y, Huang Y, Ou Q, Fang T, Tang C, Wu X, Shao YW.

Clin Lung Cancer. 2019 May;20(3):e233-e237. doi: 10.1016/j.cllc.2018.12.017. Epub 2018 Dec 31. No abstract available.

PMID:
30691963

Supplemental Content

Loading ...
Support Center